Strong Balance Sheet Stocks

Results

92

2 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

92 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	YINB2	€0.99	0%	1.0%	€24.6m	n/a	1.1	n/a	0.3%	Real Estate
	DOMO	€1.39	0%	12.1%	€15.7m	n/a	628.5	n/a	0%	Real Estate Management and Development
	RLIA	€1.04	1.5%	11.8%	€1.6b	€1.27	12.1	n/a	0%	Real Estate Management and Development
	PRM	€13.30	0%	11.8%	€223.7m	€16.75	13.6	7.7%	3.5%	Healthcare
	ART	€30.40	-5.9%	164.3%	€1.8b	€34.25	37.8	22.4%	0.5%	Capital Goods
	PHM	€76.20	-8.1%	-4.9%	€1.3b	€104.89	16.4	31.8%	1.3%	Pharmaceuticals & Biotech
	UBS	€0.0021	0%	-38.2%	€98.1m	n/a	0.6	n/a	n/a	Real Estate Management and Development
	SNG	€2.03	-3.3%	-22.5%	€113.3m	n/a	17.7	n/a	2.0%	Software
	EBRO	€18.10	0%	4.0%	€2.8b	€20.45	12.8	2.4%	3.8%	Food, Beverage & Tobacco
	NTH	€2.56	0.8%	40.3%	€154.1m	n/a	15.2	n/a	7.8%	Retail
	ITX	€53.72	-4.8%	28.0%	€170.7b	€59.14	26.6	8.5%	3.3%	Retail
	VYT	€18.00	2.3%	275.0%	€135.3m	n/a	46.7	n/a	n/a	Household
	APG	€17.00	-2.9%	3.0%	€88.5m	n/a	13.9	12.3%	5.2%	Diversified Financials
	VID	€90.40	0.1%	-1.2%	€3.2b	€102.70	15.2	7.7%	1.9%	Materials
	CIE	€25.95	-3.4%	7.5%	€3.1b	€35.34	9.1	7.8%	3.6%	Automobiles
	AZK	€14.05	-3.1%	61.1%	€347.4m	n/a	19.8	n/a	2.7%	Capital Goods
	BST	€0.20	-7.0%	-53.1%	€15.2m	n/a	4.3	n/a	n/a	Pharmaceuticals & Biotech
	ENO	€36.95	-4.4%	67.6%	€3.1b	€42.02	28.3	15.7%	8.7%	Capital Goods
	AYC	€0.55	0%	-4.4%	€18.1m	n/a	4.9	n/a	n/a	Real Estate Management and Development
	TRH	€1.00	0%	0%	€300.0k	n/a	0.3	n/a	n/a	Consumer Services
	GEST	€2.84	-2.6%	-10.7%	€1.6b	€3.50	9.2	16.3%	3.2%	Automobiles
	A3M	€4.78	-1.3%	-6.7%	€1.1b	€5.42	17.3	14.4%	8.2%	Media
	ALM	€10.74	-8.2%	-0.4%	€2.4b	€14.58	58.7	27.7%	1.7%	Pharmaceuticals & Biotech
	REP	€24.36	10.6%	88.6%	€26.6b	€24.63	11.2	2.1%	4.4%	Energy

Page 1 of 3